About R1 RCM (NASDAQ:RCM)
R1 RCM Inc. is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.
Industry, Sector and Symbol
Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
SymbolNASDAQ:RCM
CUSIP00438V10
Phone312-324-7820
Debt
Debt-to-Equity RatioN/A
Current Ratio2.25%
Quick Ratio2.25%
Price-To-Earnings
Trailing P/E Ratio-18.27
Forward P/E Ratio-53.60
P/E GrowthN/A
Sales & Book Value
Annual Sales$449.80 million
Price / Sales1.86
Cash FlowN/A
Price / CashN/A
Book Value$0.32 per share
Price / Book25.13
Profitability
EPS (Most Recent Fiscal Year)($0.44)
Net Income$-58,800,000.00
Net Margins-13.07%
Return on Equity-31.68%
Return on Assets-6.42%
Miscellaneous
Employees9,965
Outstanding Shares104,070,000
R1 RCM (NASDAQ:RCM) Frequently Asked Questions
What is R1 RCM's stock symbol?
R1 RCM trades on the NASDAQ under the ticker symbol "RCM."
How were R1 RCM's earnings last quarter?
R1 RCM Inc (NASDAQ:RCM) released its quarterly earnings results on Friday, March, 9th. The financial services provider reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.07. The financial services provider had revenue of $140.30 million for the quarter, compared to analysts' expectations of $131.20 million. R1 RCM had a negative return on equity of 31.68% and a negative net margin of 13.07%. View R1 RCM's Earnings History.
When is R1 RCM's next earnings date?
What price target have analysts set for RCM?
3 equities research analysts have issued 1-year price targets for R1 RCM's shares. Their forecasts range from $9.00 to $10.00. On average, they anticipate R1 RCM's share price to reach $9.3333 in the next twelve months. View Analyst Ratings for R1 RCM.
What are Wall Street analysts saying about R1 RCM stock?
Here are some recent quotes from research analysts about R1 RCM stock:
- 1. Cantor Fitzgerald analysts commented, "The revenue cycle management market represents a significant opportunity. Revenue cycle management remains an underdeveloped and fragmented market. There are many different solutions available, including consulting arrangements, point-solution technologies, and transactional outsourcing. Many providers use fragmented solutions. As a result, healthcare organizations are increasingly dissatisfied with currently available options and see a strong commercial partner to help improve performance and increase ROI. We estimate the market opportunity will increase to almost $70 billion by 2020. In addition, increasing consolidation among providers should lead to additional outsourcing. We expect revenue cycle outsourcing to grow to $7.7 billion by 2020 from $3.8 billion in 2015. We estimate the ambulatory market opportunity is approximately $30-40 billion. As hospital systems acquire physician offices, we expect the ambulatory market opportunity to expand." (3/13/2018)
- 2. According to Zacks Investment Research, "R1 RCM Inc. offers financial services for the health care industries. The Company provides revenue cycle management and physician advisory services, as well as transforms and manages the commercial infrastructure of health care organizations. R1 RCM Inc., formerly known as Accretive Health, Inc., is headquartered in Chicago, Illinois. " (3/1/2018)
Who are some of R1 RCM's key competitors?
Some companies that are related to R1 RCM include Westamerica Bancorporation (WABC), Safestore (SFSHF), WisdomTree Investments (WETF), First Busey (BUSE), LTC Properties (LTC), Agree Realty (ADC), Lending Club (LC), Inversiones y Representaciones Sociedad An�nima (IRSA) (IRS), McGrath RentCorp (MGRC), S&T Bancorp (STBA), Four Corners Property (FCPT), Cannae (CNNE), First BanCorp (FBP), Provident Financial (PFG), Third Point Reinsurance (TPRE), Genworth Financial (GNW), First Commonwealth Financial (FCF) and Industrial Logistics Properties Trust (ILPT).
Who are R1 RCM's key executives?
R1 RCM's management team includes the folowing people:
- Steven J. Shulman, Chairman of the Board , Independent Director (Age 65)
- Joseph Gerard Flanagan, President, Chief Executive Officer, Director (Age 45)
- Christopher Simon Ricaurte, Chief Financial Officer, Treasurer (Age 57)
- Thomas A. Lesica, Chief Operating Officer, Executive Vice President (Age 57)
- Gary Steven Long, Executive Vice President, Chief Commercial Officer
- Michael C. Feiner, Director (Age 74)
- John Bell Henneman III, Director (Age 55)
- Joseph R. Impicciche, Director (Age 59)
- Neal Moszkowski, Director (Age 51)
- Ian R. Sacks, Director (Age 46)
Has R1 RCM been receiving favorable news coverage?
News stories about RCM stock have trended somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. R1 RCM earned a daily sentiment score of 0.10 on Accern's scale. They also gave news articles about the financial services provider an impact score of 45.31 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of R1 RCM?
Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is R1 RCM's stock price today?
One share of RCM stock can currently be purchased for approximately $8.04.
How big of a company is R1 RCM?
R1 RCM has a market capitalization of $763.85 million and generates $449.80 million in revenue each year. The financial services provider earns $-58,800,000.00 in net income (profit) each year or ($0.44) on an earnings per share basis. R1 RCM employs 9,965 workers across the globe.
How can I contact R1 RCM?
R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The financial services provider can be reached via phone at 312-324-7820 or via email at [email protected]
MarketBeat Community Rating for R1 RCM (RCM)
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
R1 RCM (NASDAQ:RCM) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for R1 RCM in the last 12 months. Their average twelve-month price target is $9.3333, suggesting that the stock has a possible upside of 16.09%. The high price target for RCM is $10.00 and the low price target for RCM is $9.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Hold | Hold | Hold |
| Consensus Rating Score: | 2.67 | 2.33 | 2.00 | 2.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $9.3333 | $8.6667 | $5.00 | $5.00 |
| Price Target Upside: | 16.09% upside | 15.86% upside | 44.72% upside | 44.72% upside |
R1 RCM (NASDAQ:RCM) Consensus Price Target History
R1 RCM (NASDAQ:RCM) Analyst Ratings History
Show:
(Data available from 4/21/2016 forward)
R1 RCM (NASDAQ:RCM) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
R1 RCM (NASDAQ RCM) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 62.00%
Institutional Ownership Percentage: 48.95%
R1 RCM (NASDAQ RCM) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 8/16/2016 | John B Henneman III | Director | Buy | 50,000 | $1.80 | $90,000.00 | 100 |  |
| 8/11/2016 | Alex Mandl | Director | Buy | 200,000 | $1.59 | $318,000.00 | 65,700 | |
| 8/10/2016 | Joseph Gerard Flanagan | CEO | Buy | 100,000 | $1.56 | $156,000.00 | 1,431,814 | |
(Data available from 1/1/2013 forward)
R1 RCM (NASDAQ RCM) News Headlines
| Source: |
|
R1 RCM (NASDAQ:RCM) SEC Filings
This page is loading this company's SEC Filings. Please wait...
R1 RCM (NASDAQ:RCM) Income Statement, Balance Sheet and Cash Flow Statement
R1 RCM (NASDAQ RCM) Stock Chart for Saturday, April, 21, 2018
Loading chart…
